[A case of Paragonimus westermani complicated empyema by Streptococcus pneumoniae]

Towako Nagata1, Hiroshi Mukae, Youji Futsuki

  • 1Department of Internal Medicine, Omura City Hospital.

Insights

A case of Paragonimiasis westermani complicated by bacterial pneumonia in a 75-year-old man is presented. Prompt diagnosis and treatment with praziquantel and antibiotics led to patient recovery.

Area of Science:

  • Parasitology
  • Infectious Diseases
  • Pulmonology

Background:

  • Paragonimiasis westermani is a parasitic lung infection caused by ingesting raw or undercooked freshwater crustaceans.
  • Pleural effusion is a known complication of Paragonimiasis westermani.

Observation:

  • A 75-year-old man presented with right pleural effusion after consuming wild boar and deer.
  • Thoracentesis revealed exudative effusion with neutrophils, parasite eggs (Paragonimus species), and gram-positive cocci.

Findings:

  • The patient was diagnosed with Paragonimiasis westermani via serological study.
  • Streptococcus pneumoniae was co-identified in the pleural effusion, indicating bacterial pneumonia.
  • The pleural effusion contained a significant number of neutrophils, Paragonimus eggs, and bacteria.

Implications:

  • This case highlights the importance of considering Paragonimiasis westermani in patients with unexplained pleural effusion, especially with a history of consuming raw or undercooked crustaceans.
  • Concurrent bacterial pneumonia can complicate Paragonimiasis westermani, necessitating prompt diagnosis and combined antiparasitic and antibiotic treatment.
  • Successful management involved continuous pleural fluid drainage, praziquantel for the parasitic infection, and antibiotics for bacterial pneumonia.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: